Advertisement
Advertisement
U.S. markets close in 5 hours
Advertisement
Advertisement
Advertisement
Advertisement

ProPhase Labs, Inc. (PRPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.76+0.32 (+3.07%)
As of 10:56AM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close10.44
Open10.62
Bid10.65 x 800
Ask10.77 x 800
Day's Range10.48 - 10.76
52 Week Range4.93 - 15.25
Volume7,486
Avg. Volume177,480
Market Cap172.227M
Beta (5Y Monthly)-0.42
PE Ratio (TTM)7.27
EPS (TTM)1.48
Earnings DateNov 10, 2022 - Nov 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMay 24, 2022
1y Target Est11.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
124% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PRPH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ProPhase Labs, Inc.
    JBSS: Lowering target price to $81.00JOHN B. SANFILIPPO & SON INC has an Investment Rating of HOLD; a target price of $81.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
Advertisement
Advertisement